NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637139. A total of 10 filers reported holding NABRIVA THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Values First Advisors, Inc. | 27,262 | $41,165 | 0.02% |
| Activest Wealth Management | 13 | $9,757 | 0.01% |
| Renaissance Technologies | 22,861 | $35 | 0.00% |
| ROYAL BANK OF CANADA | 22 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 2,008 | $3,115 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 84 | $127 | 0.00% |
| WELLS FARGO & COMPANY/MN | 40 | $60 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 5,351 | $8,080 | 0.00% |
| Addison Advisors LLC | 8 | $13 | 0.00% |
This page lists NABRIVA THERAPEUTICS PLC's shareholders in Q2 2023. To view NABRIVA THERAPEUTICS PLC's shareholder history, click here.